Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Actinium Pharmaceuticals Inc (NY: ATNM ) 2.110 +0.100 (+4.98%) Official Closing Price Updated: 8:00 PM EDT, Aug 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Actinium Pharmaceuticals Inc < Previous 1 2 Next > ATNM Stock Earnings: Actinium Pharmaceuticals Beats EPS for Q2 2024 August 06, 2024 ATNM stock results show that Actinium Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket August 06, 2024 Via Benzinga S&P 500 Down Over 100 Points; Actinium Pharmaceuticals Shares Plunge August 05, 2024 Via Benzinga Topics Stocks Exposures US Equities Dow Tumbles 950 Points; ISM Services PMI Surges In July August 05, 2024 Via Benzinga Topics Stocks Exposures US Equities Actinium Pharmaceuticals Receives FDA Request For Additional Studies On Leukemia Treatment August 05, 2024 FDA rejects Actinium Pharmaceuticals' Phase 3 SIERRA trial for Iomab-B's Biologics License Application due to inadequate support despite achieving a statistically significant primary endpoint. Actinium... Via Benzinga Exposures Product Safety (ATNM) - Analyzing Actinium Pharmaceuticals's Short Interest March 09, 2023 Via Benzinga Nasdaq Tumbles 3%; Tyson Foods Earnings Top Views August 05, 2024 Via Benzinga 3 Under-$10 Biotech Stocks That Could Make You Rich July 11, 2024 Discover three under-$10 biotech stocks with potential to make you rich with huge returns on investment through an in-depth analysis. Via InvestorPlace 3 Clinical-Stage Biotech Stocks to Buy for Multibagger Returns July 02, 2024 These are the clinical-stage biotech stocks to buy, as they represent companies with an attractive product pipeline. Via InvestorPlace Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024 June 10, 2024 These are the biotech stocks under $10 that are attractively valued and have potential catalysts in the form of positive clinical trials news Via InvestorPlace Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar June 07, 2024 These are the biotech stocks to buy for a meme rally as they represent companies with positive impending news related to clinical trials. Via InvestorPlace 3 Cheap Biotech Stocks to Buy Now: May 2024 May 14, 2024 Many of these cheap biotech stocks are on their way to achieving FDA approval for their drugs to enter the market. Via InvestorPlace Exposures Product Safety ATNM Stock Earnings: Actinium Pharmaceuticals Beats EPS for Q1 2024 April 29, 2024 ATNM stock results show that Actinium Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market April 25, 2024 The radiopharmaceuticals space could be worth up to $25 billion, according to one estimate. Via Investor's Business Daily Biotech on a Budget: 7 Stocks Under $10 With Huge Potential April 15, 2024 With the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks. Via InvestorPlace High-Risk, High-Reward: Little-Known Biotech Stock ATNM Could Soar on Breakthrough Cancer Treatment March 15, 2024 ATNM stock offers moonshot or crash-landing possibilities as Actinium Pharmaceuticals works relentlessly to advance life-changing treatments. Via InvestorPlace 7 Biotech Penny Stocks on the Verge of Clinical Trial Victory February 25, 2024 Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money. Via InvestorPlace 12 Health Care Stocks Moving In Friday's After-Market Session February 09, 2024 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023 September 06, 2023 Via Benzinga Actinium Pharma – Pivotal Results From Key New Drug In The Fight Against Cancer July 14, 2023 Sandesh Seth, CEO & Chairman of the Board of Actinium Pharmaceuticals (NASDAQ: ATNM), was recently a guest on Benzinga’s All-Access. Via Benzinga Actinium Pharma Cratered 37% Over Two Days — Here's Why, According To CEO Sandesh Seth February 24, 2023 Actinium CEO Sandesh Seth says the tumble this week had little to do with clinical data. Via Investor's Business Daily Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023 February 21, 2023 Via Benzinga What's Going On With Actinium Pharmaceuticals Stock? February 21, 2023 Actinium Pharmaceuticals Inc (AMEX:ATNM) shares are trading higher Tuesday after the company announced full data results from the pivotal Phase 3 SIERRA trial in patients with active, relapsed or... Via Benzinga Why Owlet Shares Are Trading Higher By Over 45%; Here Are 20 Stocks Moving Premarket February 21, 2023 Gainers Troika Media Group Inc (NASDAQ: TRKA) shares rose 65.9% to $0.37 in pre-market trading after dropping 4% on Friday. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday February 21, 2023 It's time to start another day of trading with a breakdown of the biggest pre-market stock movers traders need to know about for Tuesday! Via InvestorPlace Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday November 23, 2022 U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses in the previous session. Via Benzinga Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday November 23, 2022 Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on... Via Benzinga Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session November 22, 2022 Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel... Via Benzinga 4 Analysts Have This to Say About Actinium Pharmaceuticals October 31, 2022 Over the past 3 months, 4 analysts have published their opinion on Actinium Pharmaceuticals (AMEX:ATNM) stock. These analysts are typically employed by large Wall Street banks and tasked with... Via Benzinga Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday November 01, 2022 Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product... Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.